
Evaluation of Pharmacokinetics and Safety of the Biosimilar (B01711) and Insulin Degludec/Insulin Aspart (IDegAsp, ...
Introduction The persistent global rise in diabetes prevalence underscores diabetes mellitus as a formidable global health challenge.1 Poor glycemic management can lead to adverse neurological and cardiac complications, resulting in suboptimal outcomes.2 …